Hudbay Minerals Inc. Ordinary Shares (Canada) vs State Street SPDR S&P Biotech ETF — how do they compare? Hudbay Minerals Inc. Ordinary Shares (Canada) trades at $26.24 (market cap $11.24B), while State Street SPDR S&P Biotech ETF trades at $149.65 (market cap $10.11B). The key difference: Hudbay Minerals Inc. Ordinary Shares (Canada) and State Street SPDR S&P Biotech ETF are close in size by market cap, and Hudbay Minerals Inc. Ordinary Shares (Canada) pays a 0.11% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hudbay Minerals Inc. Ordinary Shares (Canada) for 0 Days and State Street SPDR S&P Biotech ETF for 37 Days on average.
| HBM | XBI | |
|---|---|---|
Market Cap | $11.24B | $10.11B |
Volume | 4,316,374 | 12,903,266 |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $31.87 | $169.55 |
52-Week Low | $14.58 | $104.99 |
Typical Hold Time | 0 Days | 37 Days |
Enterprise Value | $11.30B | — |
Dividend Yield | 0.11% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $150.23, down 0.44% on the day, with a bearish technical signal driven by moving averages and oscillators. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts. Recent news highlights sector optimism from cancer vaccine breakthroughs and improved capital access, though the ETF carries higher volatility than broader healthcare funds.
The outlook is mixed: strong sector tailwinds from innovation and consolidation support growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst sentiment is neutral with 100% hold ratings, suggesting cautious optimism amid technical bearishness.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hudbay Minerals is a mining company producing copper, gold, zinc, and other metals. Its operations are located in the Americas.
Read more on HBM →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →